America Living With AIDS

SELECTED BIBLIOGRAPHY
AIDS Coalition to Unleash Power (ACT-UP). 1989. A National AIDS Treatment
Research Agenda. Distributed at the Fifth Annual International Conference on AIDS,
Montreal, June 4-9.
AIDS Coalition to Unleash Power (ACT-UP). 1990. A Capsule History of ACT-UP.
New York: ACT-UP.
AIDS Treatment Registry. 1989. Deciding to Enter an AIDS/HIV Drug Trial. New
York: AIDS Treatment Registry, Inc.
Arras, J.D. 1990. Noncompliance in AIDS research. Hastings Center Report
20:24-32.
Bayer, R. 1990. Beyond the burdens of protection: AIDS and the ethics of research.
Evaluation Review 14:443-446.
Breo, D. 1991. Tired of taking the blame, AIDS drug regulator Ellen Cooper quits.
Journal of the American Medical Association 265:1027-1028.
Byar, D.P., D.A. Schoenfeld, S.B. Green, D.A. Amato, and R. Davis. 1990. Design
considerations for AIDS trials. New England Journal of Medicine 323:1343-1347.
Cooper, E.C. 1989. Controlled clinical trials of AIDS drugs: The best hope. Journal
of the American Medical Association 261:2445.
Cotton, P. 1990. Is there still too much extrapolation from data on middle-aged
white men? Journal of the American Medical Association 263:1049-1050.
Delaney, M. 1989. The case for patient access to experimental therapy. The Journal
of Infectious Diseases 159:416-419.
Eckholm, E. 1986. Should the rules be bent in an epidemic? New York Times. July
13:E30.
Edgar, H., and D.J. Rothman. 1990. New rules for new drugs: The challenge of
AIDS to the regulatory process. The Milbank Quarterly 68(Supp. 1):1 11-142.
Erdman, K. 1989. AIDS drugs: Is the government research program a helping hand
for patients, or a handout for the pharmaceutical industry? Public Citizen
May/June: 10-13,16-17.
Freedman, B., and the McGill/Boston Research Group. 1989. Nonvalidated therapies
and HIV disease. Hastings Center Report 19(3):14-20.
Green, S.B., S.S. Ellenberg, D. Finkelstein, A.B. Forsythe, and L.S. Freedman. 1990.
Issues in the design of drug trials for AIDS. Controlled Clinical Trials 11:80-87.

I n